May 31, 2026
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma.
May 30, 2026
Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in...
May 29, 2026
In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel...
May 21, 2026
Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting.
May 14, 2026
Google DeepMind’s Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical AI system designed to augment clinical decision-making in oncology and...